Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrrence in breast carcinoma

Cancer

Volumn 91, Issue 1, 2001, Pages 17-24

  Jacobson, Arnold F ^a   Shapiro, Charles L ^b   Van Den Abbeele, Annick D ^b   Kaplan, William D ^b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Bone; Breast carcinoma; Metastasis; Radionuclide imaging

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BREAST CARCINOMA; CANCER RECURRENCE; CANCER STAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SURVIVAL TIME; VISCERA;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0035160887     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010101)91:1<17::AID-CNCR3>3.0.CO;2-K     Document Type: Article

References (47)

1. Cancer of the breast
2. The anatomy and pathways of skeletal metastases
3. Patterns of metastasis and natural courses of breast carcinoma
4. The pattern of metastases in human breast cancer
5. Bone metastases and breast cancer
6. Clinical course and prognostic factors following bone recurrence from breast cancer
7. Breast cancer with skeletal metastases at initial diagnosis. Distinctive clinical characteristics and favorable prognosis
8. Metastatic breast cancer confined to the skeletal system. An indolent disease
9. Breast cancer with bone-only metastases - Visceral metastases-free rate in relation to anatomic distribution of bone metastasis
10. Association between number and sites of new bone scan abnormalities and presence of skeletal metastases in patients with breast cancer
11. Duration of therapy in adjuvant chemotherapy trials
12. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy
13. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes
14. Nonparametric estimation from incomplete observations
15. Does early detection of bone metastases by scanning improve prognosis in breast cancer?
16. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial
17. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial
18. The significance of occult skeletal metastases, detected by skeletal scintigraphy, in patients with otherwise apparently early mammary carcinoma
19. Sequential bone scans and chest radiographs in the postoperative management of early breast cancer
20. The value of non-staging skeletal scintigraphy in breast cancer
21. A retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group adjuvant chemotherapy trials for breast cancer
22. Treatment of metastatic cancer
23. Advances in medical imaging for cancer diagnosis and treatment
24. Bone scintigraphy screening in stage I-II breast cancer: Is it cost-effective?
25. Selection of patients with breast cancer for routine follow-up bone scans
26. How far investigations for occult metastases in breast cancer aid the clinician
27. Bone scintigraphy in patients with operable breast cancer stages I and II. Final conclusion after five-year follow-up
28. Cost efficiency of bone scans in breast cancer
29. Bone scintigraphy in breast cancer: A nine-year follow-up
30. The efficacy of bone scanning in the follow-up of patients with operable breast cancer
31. The value of serial bone scanning in operable breast cancer
32. Value of bone scanning in the follow-up of breast cancer patients. A study of 1000 cases
33. Radiologic diagnosis of bone metastases
34. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases
35. Computed tomography or magnetic resonance for evaluating the solitary tumor or tumor-like lesion of bone?
36. Reappraisal of the baseline bone scan in breast cancer
37. Cost efficiency of bone scans in breast cancer
38. 18F bone scan lesions
39. Solitary abnormalities in bone scans of patients with extraosseous malignancies
40. Unifocal bone findings by scintigraphy. Clinical significance in patients with known primary cancer
41. Clinical significance of solitary rib lesions in patients with extraskeletal malignancy
42. Prognostic significance of bone metastasis from breast cancer
43. Is earlier diagnosis really better? The misleading effects of lead time and length biases
44. Detection of breast carcinoma metastases in bone: Relative merits of x-rays and skeletal scintigraphy
45. Metastatic bone disease - General perspectives, pathogenesis, pathophysiology, and skeletal dysfunction
46. Principles of molecular cell biology of cancer: Cancer metastasis
47. Stage IV breast cancer: Clinical course and survival of patients with osseous versus extraosseous metastases at initial diagnosis